FIELD: experimental medicine.
SUBSTANCE: laboratory animals should be once injected intraperitoneally or intravenously with phenylhydrazine at the dosage of 100-150 mg/kg.
EFFECT: higher efficiency.
1 cl, 4 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
METHOD FOR MODELING POSTHYPOXIC ENCEPHALOPATHY AND ENCEPHALOPATHY-ASSOCIATED DISORDERS IN BLOOD SYSTEM | 2003 |
|
RU2240604C1 |
METHOD FOR MODELING POSTHEMORRHAGIC ENCEPHALOPATHY | 2003 |
|
RU2257620C1 |
METHOD FOR MODELING ENCEPHALOPATHY IN OFFSPRING EXPOSED TO NON-TOXIC DOSES OF MANGANESE IN THE PRENATAL PERIOD | 2022 |
|
RU2794816C1 |
METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
MEDICATION POSSESSING IMMUNOTROPIC ACTIVITY | 2009 |
|
RU2406524C1 |
Authors
Dates
2005-05-27—Published
2003-07-03—Filed